I agree friend. In the old OTC we'd have been above a penny right after open. At some point the market will discover this, great to have you here

and this too from EMGE ...

https://capedge.com/filing/1463459/0001903596-23-000110/EMGE-253G2

https://capedge.com/filing/1463459/0001903596-23-000110/EMGE-253G2

Offering Circular Supplement No.2

Dated February 6, 2023

to

Post-Qualification Offering Circular Amendment No. 1 dated January 4, 2023



EMERGENT HEALTH CORP.

800,000,000 Shares of Common Stock



This Offering Circular Supplement No. 2 (the “Supplement”) supplements our Post-Qualification Offering Circular Amendment No. 1 dated January 4, 2023 (the “PQA”), which forms a part of our Offering Statement on Form 1-A (SEC File No. 024-11898), relating to the offer and sale by us of up to 800,000,000 shares of our common stock.



In the PQA, we disclosed that Garden State Securities, Inc. (“GSSI”), a FINRA-member broker-dealer, would be acting as our non-exclusive placement/selling agent in connection with this offering, pursuant to an Engagement Agreement (the “Engagement Agreement”).



This Supplement is being filed to disclose that the Engagement Agreement has been terminated by the mutual agreement of our company and GSSI. GSSI made no sales of the Offered Shares pursuant to the Engagement Agreement.



This Supplement should be read in conjunction with, and may not be delivered or utilized without, the PQA, including any amendments or supplements to it.



We may elect to satisfy our obligation to deliver a Final Offering Circular by sending you a notice within two business days after the completion of our sale to you that contains the URL where the Final Offering Circular or the Offering Statement in which such Final Offering Circular was filed may be obtained.

One of the few I have had true patience on ... not my strong suite ... lol

Added some ECSL today. Rumor we hear from the company this week ...

I live in New Hampshire and have a nice stack of the NH Goldbacks, a small number of folks out here actually use them for trading and I occassionally drop one in a tip jar ...

$SDRC - Gold
$PSGR - Copper
$CFTN - Gold
$BYRG - PGMs
$BRGC - Lithium
$XTPT - Antimony
$XCPT - Nickel
$SBUM - Silver
$VINS - Silver

Thank you!

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171102838

that big seller got fleeced ... nice

added on that dip ... CLNV

URNJ

.006 next key break ...

News flow has been great with EMGE. I believe back in the old OTC we'd be multi pennies by now. Think our day will come here, time will tell ...

EMGE

Outstanding Shares
273,351,111
01/27/2023
Restricted
51,827,516
01/27/2023
Unrestricted
221,523,595
01/27/2023

hard to not be excited about GDVM. I finally grabbed some GVSI, would be nice if Sharp pulls off another TSNP there, classic Ihub on that board ... lol

Uranium - SYBHF

Uranium - ISNEF

URANIUM

agree, it may still be early here. best of luck in all your trades ...

Nice action OTC today ...

Big push there ...

EMGE .0056 maybe finally turning. Nice SS and company been putting out lots of news. Holding gains first time in a long time

i picked a few more early this morning. holding gains so far, it's been a long time. multi bag potential here ... imo

the potential is here ...

Looks like they are really building a company here ... I think I'm actually seeing sustained buying here

https://www.otcmarkets.com/stock/EMGE/news/story?e&id=2433124

Emergent Executes "Letter of Intent" to Acquire Nanosthetic, a Biologics Company That Manufacturers Products to be Sold and Marketed by Evolutionary Biologics
NEW YORK, NY / ACCESSWIRE / January 26, 2023 / Emergent Health Corp. (OTC PINK:EMGE), a curator, developer and marketer of products in the Regenerative Health Space announced today that it has executed a "Letter of Intent" to acquire Nanosthetic Corp. ("Nanosthetic"), a biologics company that manufacturers products sold and marketed by Emergent subsidiary Evolutionary Biologics. The combined entities intend to operate a "Cleanroom" after obtaining FDA clearance for products providing the ability to do clinical trials, testing, and creation of pharmaceutical grade products. A pharmaceutical cleanroom is a controlled environment where pollutants like dust, airborne microbes, and aerosol particles are filtered out to provide the cleanest area possible. Most cleanrooms are used for manufacturing products such as electronics, pharmaceutical products, and medical equipment.

Sandy Lipkins, the Managing Member of Nanosthetic is the former CEO of BioTherapeutic Labs Corp. ("BTL"), an FDA registered life sciences company dedicated to the research, development, manufacturing, and distribution of cutting-edge anti-aging, aesthetic, muscle-skeletal, wound care, and hair loss therapy products. BTL committed itself to the advancement of products and therapies utilizing human biologics to their fullest potential. BTL manufactured its products in a cGMP compliant facility, specializing in the production of aseptic umbilical cord-derived products for regenerative therapies. Nanosthetic's new proprietary sterile processing techniques produce products which are endotoxin and microorganism free, while maintaining the structural integrity of the tissue(s). The transaction is subject to due-diligence, negotiation of definitive agreements, and a commitment after closing of funding to purchase equipment and construction of the cleanroom.

Sandy Lipkins, Managing Member of Nanosthetic stated, "The team at Nanosthetic has spent the last year in R&D on both product development and on the regulatory side to produce a novel cosmetic that does not exist yet, that has not been seen in this market. With the experience of Jim Morrison and his outstanding team we will create a market that has been woefully underserved until now."

Jim Morrison, Former President of L'Oréal and current CEO of Emergent stated, "Since taking over as CEO of Emergent I have been very focused on two goals; to find synergistic companies that EMGE can acquire or merge with, that help the company accelerate the top line and to evolve Emergent into a company that is vertically integrated in the natural health, and regenerative wellness space. The Nanosthetic union does both. Nanosthetic absolutely makes Emergent a vertically integrated 'biologics company' and will result in additional revenue from the Evolutionary Biologics division, right out of the gate. Additions like The Wholistic Company and Integrity Wellness have built a strong portfolio that Emergent will bring to market in 2023."

ABOUT EMERGENT HEALTH CORPORATION

Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through "Content Based Shopping" using "Influencers" to successfully position products throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy, and Pet Wellness. I will also utilize Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent asserts that its products are not approved by the FDA to diagnose, treat, cure or prevent any disease(s). For more information, please visit Emergent's Website and Social Media on Twitter and Linkedin.

Before using any products, you should always consult with your veterinarian and/or family doctor.

https://twitter.com/Swedish_uranium/status/1617858255967113219

FISOF

https://twitter.com/Swedish_uranium/status/1617858255967113219

Sure hope it happens

Some thoughts about $FUU, $SUU, $WUC and other #uranium stocks near-term:
I think $FUU will be included this time in $URA, which means we will see big volumes until month-end, probably starting early next week. Around 12M shares to be bought if my calculations are correct.

— Anders (@Swedish_uranium) January 20, 2023

some clown keeps hitting that bid with1000 shares ... lol

I almost got impatient there, thankfully not ...

Word is $URA fund is including FUU/FISOF so buying shares now. What ever is happening lookie good here ...

Nice to see ...

lookin' much betta ...

.3466 ... keeping a core of this one

No money in the OTC right now, just a few plays with volume. On paper EMGE looks great in this range, when/if the market catches up? I have no idea ...

PTUUF

Emergent Intends to Become a Fully Reporting SEC Issuer and List its Shares on the OTCQB

https://www.accesswire.com/734573/Emergent-Intends-to-Become-a-Fully-Reporting-SEC-Issuer-and-List-its-Shares-on-the-OTCQB

NEW YORK, NY / ACCESSWIRE / January 10, 2023 / Emergent Health Corp. (OTC PINK:EMGE), a curator, developer and marketer of products in the Regenerative Health Space announced today that it intends to retain an independent certified public accountant to audit Emergents financial statements in accordance with Securities and Exchange Commission ("SEC") Generally Accepted Accounting Principles ("GAAP") and an experienced Securities Attorney to prepare and file either Form 10 or Form S-1 Registration Statement with the SEC to become a fully reporting SEC Company subject to the filing requirements of Section 15(d) of the Securities Exchange Act of 1934. This action is fundamental to the Company's efforts to demonstrate heightened transparency to its investors and bring the Company greater visibility and credibility before a substantially larger group of qualified investors. The Company hopes to file either Form 10 or Form S-1 during the 3rd quarter of 2023.

Additionally, Emergent is planning to up-list to the OTCQB. In order to qualify for listing, Emergent must (1) have audited annual financials by a PCAOB auditor (2) meet minimum bid price test of $0.01 per share (3) not be in bankruptcy (4) have at least 50 Beneficial Shareholders, each owning at least 100 shares and (5A) have a freely traded Public Float of at least 10% of the total issued and outstanding shares or (5B) have a freely traded Public Float of at least 5% and $2 million in market value of public float. The Company hopes to file for listing on the OTCQB also during the 3rd quarter of 2023.

Jim Morrison, Former President of L'Oréal and current CEO of Emergent stated "We believe we're developing a business model deserving a stronger presence in the financial markets. Since I became CEO in August 2022, we've had consecutive strong revenue gains quarter-to-quarter and increased our market share with the plan to pick up the pace and continue. We're now poised and ready to become a fully reporting SEC Company. Our continued growth, transparency by audit and the requirements set forth as a fully-reporting SEC company, sets the stage for significant opportunities for Emergent Health and its shareholders."

ABOUT OTCQB
The OTCQB market contains a one penny ($0.01) bid price requirement "intended to remove companies that are most likely to be the subject of dilutive stock fraud schemes and promotions". Each company verifies via an annual OTCQB Certification, signed by the company CEO or CFO, that their company information is current, including information about a company's reporting status, company profile, information on management and boards, major shareholders, law firms, transfer agents, and IR / PR firms. Investor confidence improves when there is more information about a company's ownership structure, professional advisors and service providers. This certification will be required for any security newly qualified to be publicly quoted by a broker-dealer under SEC Rule 15c2-11, or when a Pink traded company becomes a current SEC reporting company, beginning May 1, 2014. International Reporting companies are also allowed to upgrade from Pink to OTCQB if they publish their 12g3-2(b) compliant disclosure online and verify their company profile. There is an annual fee for the OTCQB market of $10,000 per year and a one-time $2,500 application fee.

ABOUT ("PCAOB") PUBLIC COMPANY ACCOUNTING OVERSIGHT BOARD
The Public Company Accounting Oversight Board (PCAOB) is a private-sector, nonprofit corporation created by the Sarbanes-Oxley Act of 2002 to oversee the audits of public companies and other issuers in order to protect the interests of investors and further the public interest in the preparation of informative, accurate and independent audit reports.

ABOUT EMERGENT HEALTH CORPORATION
Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter and Linkedin.

Before using any products, you should always consult with your veterinarian and/or family doctor.

Emergent Intends to Become a Fully Reporting SEC Issuer and List its Shares on the OTCQB

https://www.accesswire.com/734573/Emergent-Intends-to-Become-a-Fully-Reporting-SEC-Issuer-and-List-its-Shares-on-the-OTCQB

NEW YORK, NY / ACCESSWIRE / January 10, 2023 / Emergent Health Corp. (OTC PINK:EMGE), a curator, developer and marketer of products in the Regenerative Health Space announced today that it intends to retain an independent certified public accountant to audit Emergents financial statements in accordance with Securities and Exchange Commission ("SEC") Generally Accepted Accounting Principles ("GAAP") and an experienced Securities Attorney to prepare and file either Form 10 or Form S-1 Registration Statement with the SEC to become a fully reporting SEC Company subject to the filing requirements of Section 15(d) of the Securities Exchange Act of 1934. This action is fundamental to the Company's efforts to demonstrate heightened transparency to its investors and bring the Company greater visibility and credibility before a substantially larger group of qualified investors. The Company hopes to file either Form 10 or Form S-1 during the 3rd quarter of 2023.

Additionally, Emergent is planning to up-list to the OTCQB. In order to qualify for listing, Emergent must (1) have audited annual financials by a PCAOB auditor (2) meet minimum bid price test of $0.01 per share (3) not be in bankruptcy (4) have at least 50 Beneficial Shareholders, each owning at least 100 shares and (5A) have a freely traded Public Float of at least 10% of the total issued and outstanding shares or (5B) have a freely traded Public Float of at least 5% and $2 million in market value of public float. The Company hopes to file for listing on the OTCQB also during the 3rd quarter of 2023.

Jim Morrison, Former President of L'Oréal and current CEO of Emergent stated "We believe we're developing a business model deserving a stronger presence in the financial markets. Since I became CEO in August 2022, we've had consecutive strong revenue gains quarter-to-quarter and increased our market share with the plan to pick up the pace and continue. We're now poised and ready to become a fully reporting SEC Company. Our continued growth, transparency by audit and the requirements set forth as a fully-reporting SEC company, sets the stage for significant opportunities for Emergent Health and its shareholders."

ABOUT OTCQB
The OTCQB market contains a one penny ($0.01) bid price requirement "intended to remove companies that are most likely to be the subject of dilutive stock fraud schemes and promotions". Each company verifies via an annual OTCQB Certification, signed by the company CEO or CFO, that their company information is current, including information about a company's reporting status, company profile, information on management and boards, major shareholders, law firms, transfer agents, and IR / PR firms. Investor confidence improves when there is more information about a company's ownership structure, professional advisors and service providers. This certification will be required for any security newly qualified to be publicly quoted by a broker-dealer under SEC Rule 15c2-11, or when a Pink traded company becomes a current SEC reporting company, beginning May 1, 2014. International Reporting companies are also allowed to upgrade from Pink to OTCQB if they publish their 12g3-2(b) compliant disclosure online and verify their company profile. There is an annual fee for the OTCQB market of $10,000 per year and a one-time $2,500 application fee.

ABOUT ("PCAOB") PUBLIC COMPANY ACCOUNTING OVERSIGHT BOARD
The Public Company Accounting Oversight Board (PCAOB) is a private-sector, nonprofit corporation created by the Sarbanes-Oxley Act of 2002 to oversee the audits of public companies and other issuers in order to protect the interests of investors and further the public interest in the preparation of informative, accurate and independent audit reports.

ABOUT EMERGENT HEALTH CORPORATION
Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter and Linkedin.

Before using any products, you should always consult with your veterinarian and/or family doctor.

exactly, just a few but could really move ... thx

took some 5s ...